什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001920938
申报总市值
US$27.0亿
US$27.0亿
73 檔
27.6%
Braidwell LP 在 Q4 2024 季度的美股仓位总计估值为 US$27.0亿,分散于 73 个持仓标的之中,反映其市场参与广度与投资规模。
Braidwell LP 在 Q4 2024 进行了结构性的板块轮动与仓位换股。在开立 14 个全新仓位及加仓 23 档持股的同时,亦同步清仓 22 档并减仓 17 档标的。
在资产配置集中度方面,Braidwell LP 的前 5 大核心持股(包含 GH 0 11-15-27, BBIO 2.5 03-15-27, NVCR 0 11-01-25 等)合计占整体申报市值的 27.6%,反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 0 11-15-27债券 | Guardant Health Inc | 债券 | 6.70% | — | — | |
| 2 | BBIO 2.5 03-15-27债券 | Bridgebio Pharma Inc | 债券 | 4.39% | — | — | |
| 3 | NVCR 0 11-01-25债券 | Novocure LTD | 债券 | 3.99% | — | — | |
| 4 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 3.65% | -0.77% | -1.73% | |
| 5 | RGEN 1 12-15-28债券 | Repligen CORP | 债券 | 3.40% | -2.68% | — | |
| 6 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 3.39% | -0.07% | +7.64% | |
| 7 | GMED 0.375 03-15-25债券 | Nuvasive Inc | 债券 | 3.36% | — | — | |
| 8 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 债券 | 2.91% | -2.44% | — | |
| 9 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 2.87% | — | +93.18% | |
| 10 | CGON | Cg Oncology Inc | 股票-其他 | 2.79% | -2.22% | EXIT | |
| 11 | GH | Guardant Health Inc | 股票-医疗保健 | 2.58% | -0.72% | -14.79% | |
| 12 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | 债券 | 2.53% | — | — | |
| 13 | ALGN | Align Technology Inc | 股票-医疗保健 | 2.32% | — | +20.37% | |
| 14 | DXCM 0.375 05-15-28债券 | Dexcom Inc | 债券 | 2.21% | — | -10.79% | |
| 15 | APGE | Apogee Therapeutics Inc | 股票-其他 | 2.07% | -1.34% | EXIT | |
| 16 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 2.02% | -0.01% | +19.28% | |
| 17 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 1.99% | — | -32.84% | |
| 18 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 1.89% | +0.48% | -9.86% | |
| 19 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 1.85% | +0.53% | +19.09% | |
| 20 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 1.83% | — | — | |
| 21 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.78% | +1.32% | +17.74% | |
| 22 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 1.77% | — | +27.89% | |
| 23 | TMDX | Transmedics Group Inc | 股票-医疗保健 | 1.70% | +0.41% | — | |
| 24 | ATEC 0.75 08-01-26债券 | Alphatec Holdings Inc | 债券 | 1.63% | — | — | |
| 25 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.61% | -0.05% | +22.81% | |
| 26 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 1.47% | -1.46% | -16.50% | |
| 27 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 1.38% | +0.14% | — | |
| 28 | BBIO 2.25 02-01-29债券 | Bridgebio Pharma Inc | 债券 | 1.36% | — | — | |
| 29 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 1.35% | +1.04% | — | |
| 30 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 1.32% | — | -1.48% | |
| 31 | PEN | Penumbra Inc | 股票-医疗保健 | 1.29% | -1.15% | EXIT | |
| 32 | GKOS | Glaukos CORP | 股票-医疗保健 | 1.28% | +0.32% | -7.30% | |
| 33 | ✓ | Avadel Pharmaceuticals PLC ADR | 股票-其他 | 1.28% | — | +21.15% | |
| 34 | RGEN | Repligen CORP | 股票-医疗保健 | 1.21% | +0.70% | -28.47% | |
| 35 | FNAUSD | Paragon 28 Inc | 股票-其他 | 1.17% | — | -7.26% | |
| 36 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.17% | -0.16% | -17.52% | |
| 37 | ATEC | Alphatec Holdings Inc | 股票-其他 | 1.16% | +1.30% | +5.33% | |
| 38 | BNTX | Biontech Se-adr | 股票-其他 | 1.05% | — | +25.07% | |
| 39 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 1.03% | — | +20.70% | |
| 40 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 0.93% | +0.20% | +18.86% | |
| 41 | HROW | Harrow Inc | 股票-其他 | 0.90% | -0.18% | EXIT | |
| 42 | KROS | Keros Therapeutics Inc | 股票-其他 | 0.89% | — | +167.86% | |
| 43 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.80% | +0.98% | NEW | |
| 44 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 0.78% | -0.38% | +144.40% | |
| 45 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.76% | +0.20% | — | |
| 46 | ✓ | Immatics NV | 股票-其他 | 0.74% | — | +112.68% | |
| 47 | GERN | Geron CORP | 股票-其他 | 0.74% | — | — | |
| 48 | IRWD | Ironwood Pharmaceuticals Inc | 股票-其他 | 0.71% | — | +22.58% | |
| 49 | BRKR | Bruker CORP | 股票-医疗保健 | 0.61% | — | — | |
| 50 | EXK | Exact Sciences CORP | 股票-原材料 | 0.59% | — | +23.35% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | RGEN 1 12-15-28债券 | Repligen CORP | +3.4% | NEW | 新建仓 |
| 2 | TMDX | Transmedics Group Inc | +1.7% | NEW | 新建仓 |
| 3 | TMO | Thermo Fisher Scientific Inc | +1.4% | NEW | 新建仓 |
| 4 | GERN | Geron CORP | +0.7% | NEW | 新建仓 |
| 5 | LEGN | Legend Biotech Corp-adr | +0.7% | +93.18% | 加仓 |
| 6 | NBIX | Neurocrine Biosciences Inc | +0.7% | -1.73% | 减仓 |
| 7 | BRKR | Bruker CORP | +0.6% | NEW | 新建仓 |
| 8 | GH 0 11-15-27债券 | Guardant Health Inc | +0.6% | — | 不变 |
| 9 | NUVL | Nuvalent Inc-a | +0.6% | NEW | 新建仓 |
| 10 | ATEC | Alphatec Holdings Inc | +0.5% | +5.33% | 加仓 |
| 11 | DYN | Dyne Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 12 | ORKA | Oruka Therapeutics Inc | +0.4% | +122.54% | 加仓 |
| 13 | CADL | Candel Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 14 | GH | Guardant Health Inc | +0.4% | -14.79% | 减仓 |
| 15 | DNTH | Dianthus Therapeutics Inc | +0.4% | +144.40% | 加仓 |
| 16 | FNAUSD | Paragon 28 Inc | +0.4% | -7.26% | 减仓 |
| 17 | EWTX | Edgewise Therapeutics Inc | +0.4% | +19.09% | 加仓 |
| 18 | XENE | Xenon Pharmaceuticals Inc | +0.4% | +7.64% | 加仓 |
| 19 | RCUS | Arcus Biosciences Inc | +0.4% | NEW | 新建仓 |
| 20 | HROW | Harrow Inc | +0.3% | +106.31% | 加仓 |
| 21 | BBIO 2.5 03-15-27债券 | Bridgebio Pharma Inc | +0.3% | — | 不变 |
| 22 | IRTC | Irhythm Holdings Inc | +0.2% | -9.86% | 减仓 |
| 23 | BNTX | Biontech Se-adr | +0.2% | +25.07% | 加仓 |
| 24 | ✓ | Immatics NV | +0.2% | +112.68% | 加仓 |
| 25 | NVCR 0 11-01-25债券 | Novocure LTD | +0.2% | — | 不变 |
| 26 | JSPR | Jasper Therapeutics Inc | +0.2% | +47.87% | 加仓 |
| 27 | IRWD | Ironwood Pharmaceuticals Inc | +0.2% | +22.58% | 加仓 |
| 28 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | +0.2% | — | 不变 |
| 29 | GMED 0.375 03-15-25债券 | Nuvasive Inc | +0.2% | — | 不变 |
| 30 | INSP | Inspire Medical Systems Inc | +0.2% | +22.81% | 加仓 |
| 31 | CBLL | Ceribell Inc | +0.2% | NEW | 新建仓 |
| 32 | NEO 0.25 01-15-28债券 | Neogenomics Inc | +0.2% | — | 不变 |
| 33 | XNCR | Xencor Inc | +0.2% | +31.96% | 加仓 |
| 34 | ATEC 0.75 08-01-26债券 | Alphatec Holdings Inc | +0.1% | — | 不变 |
| 35 | GKOS | Glaukos CORP | +0.1% | -7.30% | 减仓 |
| 36 | ✓ | +0.1% | NEW | 新建仓 | |
| 37 | BBIO 2.25 02-01-29债券 | Bridgebio Pharma Inc | +0.1% | — | 不变 |
| 38 | SKYE | Skye Bioscience Inc | +0.1% | NEW | 新建仓 |
| 39 | ALGN | Align Technology Inc | +0.1% | +20.37% | 加仓 |
| 40 | KRYS | Krystal Biotech Inc | +0.1% | +18.86% | 加仓 |
| 41 | EXK | Exact Sciences CORP | 0% | +23.35% | 加仓 |
| 42 | ✓ | Avadel Pharmaceuticals PLC ADR | 0% | +21.15% | 加仓 |
| 43 | PTGX | Protagonist Therapeutics Inc | 0% | NEW | 新建仓 |
| 44 | VRDN | Viridian Therapeutics Inc | 0% | NEW | 新建仓 |
| 45 | SRPT | Sarepta Therapeutics Inc | 0% | -1.48% | 减仓 |
| 46 | ✓ | Elevation Oncology Inc | 0% | EXIT | 清仓 |
| 47 | ARGX | Argenx Se - Adr | 0% | -16.50% | 减仓 |
| 48 | KNSA | Kiniksa Pharmaceuticals International, plc | 0% | +19.28% | 加仓 |
| 49 | CELC | Celcuity Inc | 0% | — | 不变 |
| 50 | ✓ | Dbv Technologies S A | 0% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案,Braidwell LP 在 Q4 2024 季度的美股持仓总市值约为 US$27.0亿,共申报了 73 个公开持股仓位。
在 Q4 2024 季度,Braidwell LP 按市值排列的前三大核心持股分别为:GH 0 11-15-27 (6.7%)、BBIO 2.5 03-15-27 (4.4%)、NVCR 0 11-01-25 (4.0%)。其中最大持股仓位 GH 0 11-15-27 占据整体投资组合约 6.7% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
RGEN 1 12-15-28
市值: US$1.1亿
本季最大获利了结 / 清仓标的
PODD 0.375 09-01-26
前期市值: US$7638.5万
在 Q4 2024 季度中,Braidwell LP 共进行了 76 项持仓异动,包含新建仓 14 个仓位、加仓 23 个仓位、减仓 17 个仓位以及清仓 22 个仓位。 其中最大新建仓标的为 RGEN 1 12-15-28。 本季清仓仓位包含 PODD 0.375 09-01-26。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。